English Korean Chinese
ホーム > ニューズレター > 医薬品 > Anti-Infective Drug News
ニューズレターカテゴリ
バイオテクノロジー (11)
医薬品 (28)
医療機器 (7)
通信/IT (62)
電子部品/半導体 (7)
自動車 (5)
エネルギー (7)
環境 (4)
防衛/航空宇宙 (7)
マテリアル (21)
産業用機械 (1)
建築/土木 (3)
金融/保険 (27)
食料/飲料 (21)
一般消費財 (12)
ニューズレター

Anti-Infective Drug News

発行 Espicom Business Intelligence
発行回数 22 回/年 商品コード 6035
ページ情報 英文  
価格
US$ 1,025 換算 ¥ 82,492 (税抜) 1 Year Web Access (Single User License)
US$ 1,025 換算 ¥ 82,492 (税抜) 1year Hard Copy
US$ 1,025 換算 ¥ 82,492 (税抜) 1year PDF by e-mail


原文目次

Anti-Infective Drug News: Monitoring Antibiotic & Antiviral Drug Developments Worldwide

Current and detailed coverage of the latest antibiotic & antiviral drug developments worldwide

How things change. Twenty years ago the anti-infective sector was characterised by new issues of largely derivative products and antivirals with specific therapeutic action. Over time, though, the area has become one of the most attractive with many issues reaching the popular press - eg AIDS/HIV, greater disease resistance to antibiotics and the controversy surrounding the novel new influenza treatments.

The amount of information around is bewildering which is why busy executives will appreciate Anti - Infective News (AIN).

AIN makes tracking drug & company developments in the anti-infective area easy. Every 36+ page issue is comprehensively indexed and packed with key information on:

  • News by anti-infective sector
    R&D, product and agreement news by anti-infective type including:
      Antibacterials
      Antifungals
      Anti mycobacterials
      Antivirals
      HIV/AIDS
      Antiprotozoals/ antianthelmintics.

  • General Development News
    R&D, product and agreement news for non-condition specific anti-infective agents.

  • Conference Listings
    A round up of upcoming meetings, conferences and seminars.
  • Back to Top